Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹20Cr
Rev Gr TTM
Revenue Growth TTM
339.71%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DAIKAFFI
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -100.0 | -100.0 | -100.0 | | | | | | | | | -58.0 |
| 0 | 0 | 0 | 0 | 1 | 0 | 1 | 4 | 4 | 3 | 7 | 2 |
Operating Profit Operating ProfitCr |
| | | | | | | | -1.4 | -10.3 | 13.4 | -21.0 | -19.7 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | 0 | 0 | 0 | -1 | 0 | -1 | 0 | 0 | 0 | -1 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -148.0 | 48.8 | 50.0 | 40.4 | -53.2 | 30.2 | -141.7 | -28.6 | 63.2 | 240.0 | -131.0 | 5.6 |
| | | | | | | | -10.3 | -8.8 | 10.8 | -22.2 | -23.1 |
| -1.0 | -0.7 | -0.4 | -0.5 | -1.6 | -0.5 | -1.0 | -0.6 | -0.6 | 0.7 | -2.2 | -0.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 3.2 | -20.4 | -3.7 | -13.7 | -26.2 | -6.7 | -27.5 | -28.5 | -92.2 | -100.0 | | 105.3 |
| 32 | 24 | 22 | 20 | 15 | 14 | 11 | 10 | 3 | 2 | 9 | 17 |
Operating Profit Operating ProfitCr |
| 8.5 | 11.4 | 17.5 | 14.3 | 10.4 | 11.7 | 1.5 | -24.9 | -305.0 | | -24.0 | -9.4 |
Other Income Other IncomeCr | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| 2 | 3 | 4 | 3 | 1 | 2 | 0 | -3 | -2 | -2 | -2 | -2 |
| 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 8.1 | 35.5 | 16.3 | -1.9 | -64.1 | 25.7 | -137.4 | -518.1 | 14.8 | 10.8 | 16.4 | -1.3 |
| 4.5 | 7.7 | 9.3 | 10.5 | 5.1 | 6.9 | -3.5 | -30.7 | -334.9 | | -21.2 | -10.5 |
| 2.6 | 3.5 | 4.1 | 4.0 | 1.4 | 1.8 | -0.7 | -4.2 | -4.0 | -3.2 | -2.6 | -2.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| 5 | 7 | 18 | 20 | 19 | 20 | 20 | 19 | 6 | 5 | 3 | 2 |
Current Liabilities Current LiabilitiesCr | 8 | 6 | 2 | 4 | 2 | 3 | 2 | 1 | 0 | 1 | 5 | 7 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 14 | 13 | 12 | 13 | 14 | 16 | 15 | 12 | 10 | 10 | 11 | 11 |
Non Current Assets Non Current AssetsCr | 6 | 6 | 16 | 17 | 15 | 14 | 14 | 14 | 3 | 2 | 3 | 4 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 2 | 1 | 5 | 3 | 2 | 3 | 0 | -1 | -8 | 6 | -6 |
Investing Cash Flow Investing Cash FlowCr | -1 | 0 | -1 | -3 | 2 | 0 | 0 | 0 | 1 | 1 | -1 |
Financing Cash Flow Financing Cash FlowCr | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 1 | 0 | 4 | 2 | 2 | 3 | 0 | -1 | -8 | 6 | -7 |
| 111.3 | 34.5 | 206.3 | 110.7 | 264.5 | 313.5 | -53.0 | 34.3 | 381.3 | -311.1 | 396.3 |
CFO To EBITDA CFO To EBITDA% | 59.0 | 23.2 | 109.0 | 81.3 | 129.8 | 184.4 | 127.3 | 42.2 | 418.6 | -262.8 | 350.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 14 | 16 | 38 | 34 | 22 | 11 | 16 | 14 | 13 | 59 | 114 |
Price To Earnings Price To Earnings | 9.1 | 7.5 | 15.7 | 14.2 | 26.1 | 9.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.4 | 0.6 | 1.4 | 1.5 | 1.3 | 0.7 | 1.4 | 1.7 | 19.9 | | 15.2 |
Price To Book Price To Book | 1.3 | 1.3 | 2.5 | 2.0 | 1.3 | 0.6 | 0.9 | 1.0 | 1.0 | 5.6 | 12.9 |
| 5.0 | 4.9 | 7.3 | 9.4 | 9.0 | 0.8 | 39.0 | -2.5 | -5.8 | -22.4 | -62.7 |
Profitability Ratios Profitability Ratios |
| 33.4 | 34.7 | 41.9 | 41.3 | 42.1 | 42.6 | 36.9 | 28.3 | 20.9 | | 32.8 |
| 8.5 | 11.4 | 17.5 | 14.3 | 10.4 | 11.7 | 1.5 | -24.9 | -305.0 | | -24.0 |
| 4.5 | 7.7 | 9.3 | 10.5 | 5.1 | 6.9 | -3.5 | -30.7 | -334.9 | | -21.2 |
| 18.0 | 24.6 | 15.2 | 12.3 | 4.9 | 5.9 | -1.5 | -10.8 | -16.7 | -18.0 | -18.1 |
| 13.8 | 16.7 | 10.0 | 9.4 | 3.4 | 4.2 | -1.6 | -10.2 | -17.1 | -18.1 | -18.0 |
| 7.8 | 11.1 | 8.8 | 7.9 | 3.1 | 3.6 | -1.4 | -9.5 | -16.8 | -16.1 | -11.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Daikaffil Chemicals India Limited is an Indian specialty chemicals manufacturer currently undergoing a strategic transformation. Following its acquisition in **2023-24**, the company has transitioned into a **step-down subsidiary of Heranba Industries Limited**, a major player in the agrochemical sector. Historically focused on **Optical Brightening Agents (OBA)** and **Dye Intermediates**, the company is now pivoting toward high-value research and global contract manufacturing.
---
### **Corporate Structure and Ownership Transition**
The company recently underwent a formal change in control, integrating into the **Heranba Group** to diversify the parent group's chemical portfolio.
* **Ultimate Holding Company:** **Heranba Industries Limited** (HIL).
* **Direct Parent Company:** **Mikusu India Private Limited**, which acquired an initial **48.48%** stake in **January 2024** via a Share Purchase Agreement at **₹24 per share**.
* **Regulatory Reclassification:** In **March 2025**, the BSE approved the reclassification of former promoters to the **'Public' category**, formalizing the Heranba Group’s leadership.
* **Global Footprint:** In **August 2025**, the company incorporated **Mikusu Global Industries Limited** in **Nigeria** and approved a second subsidiary in the **UAE** to facilitate international expansion.
---
### **Specialized Product Portfolio and Market Applications**
The company operates in the **Organic Dyes and Intermediaries** segment, utilizing **Japanese technology** to maintain a quality premium over regional competitors.
| Product Category | Primary Function | Key End-Use Industries |
| :--- | :--- | :--- |
| **Optical Brighteners** | Fluorescent agents that absorb **UV light** and re-emit it in the **blue spectrum** to mask yellowing. | **Plastics, Fibers, Coatings, Inks, Detergents,** and **Uncoated Fine Paper**. |
| **Naphthol Grounders** | Organic compounds used as a base for manufacturing **Organic Pigments** and **Masterbatches**. | **Paints, Printing Inks, Fabrics, Cosmetics,** and **Food Colorants**. |
**Key Market Insights:**
* **Optical Brighteners:** Essential for high-whiteness paper containing **High-Yield Pulp (HYP)** and for plastics requiring **high-temperature processing**.
* **Naphthol:** Produced to **Japanese quality** standards; currently exported to MNCs in **Japan** and experiencing rapid demand growth in **Europe**.
---
### **Strategic Pivot: CRAMS, CRO, and CDMO**
Under new leadership, Daikaffil is shifting from a niche manufacturer to a diversified service provider in the global life sciences supply chain.
* **R&D Investment:** The company is establishing a world-class **Research and Development (R&D) centre** to enter the **Contract Research and Manufacturing Services (CRAMS)** and **CDMO** segments.
* **Sector Targeting:** Strategy focuses on long-term partnerships with MNCs in the **agrochemical, pharmaceutical, biopharmaceutical, and specialty chemicals** sectors.
* **Capacity Expansion:** Management is evaluating capacity increases for Naphthol grounders, contingent upon **Maharashtra Pollution Control Board (MPCB)** approvals.
---
### **Operational Status and Infrastructure**
The company’s manufacturing operations have faced recent volatility, leading to a temporary shift in the business model.
* **Manufacturing Facility:** Located at **Plot No. E-4, M.I.D.C. Tarapur, Boisar (Maharashtra)**.
* **Operational Restart:** The facility underwent a **planned shutdown** in **November 2021** due to high fixed costs and low orders. Following the acquisition, the company withdrew its closure notice and is currently restoring manufacturing capacity as sales orders normalize.
* **Interim Trading Strategy:** During the shutdown, the company sustained margins by **trading** in Dyes and Dye Intermediates.
* **Real Estate Assets:** Holds freehold land at **Delisle Road, Mumbai** and residential property in **Navi Mumbai**.
* **Accounting Alignment:** In **FY 2023-24**, the company transitioned its **Property, Plant and Equipment (PPE)** accounting from a **Revaluation model to a Cost model** to align with Heranba Industries Limited.
---
### **Financial Performance and Capital Structure**
While the company has faced historical losses, recent projections indicate a sharp recovery in top-line growth.
**Comparative Financial Summary:**
| Metric | **FY 2024-25 (Proj/Curr)** | **FY 2023-24** | **FY 2022-23** |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **₹ 7.97 Crore** | **₹ 71.11 Lakh** | **₹ 1.05 Crore** |
| **Loss After Tax (LAT)** | **₹ 1.59 Crore** | **₹ 1.90 Crore** | **₹ 2.13 Crore** |
| **Sales Growth (Total)** | **100%** | **NIL** | **(92.19%)** |
| **Cash & Equivalents** | **₹ 66.01 Lakh** | **₹ 7.52 Crore** | - |
**Capital and Liquidity Management:**
* **Authorized Capital:** Increased from **₹6.50 Crore** to **₹10.00 Crore** in **April 2025** to support expansion.
* **Borrowing Limits:** Shareholders approved an increase in borrowing limits to **₹200 Crore** in **August 2024**.
* **Related Party Framework:** A three-year **(2024-2027)** framework is in place for transactions with the Heranba Group, including **Inter-Corporate Deposits (ICDs)** and guarantees.
---
### **Risk Profile and Mitigation**
The company operates under a board-approved risk management framework to address operational and macroeconomic headwinds.
* **Going Concern Status:** Statutory auditors have noted **Material Uncertainty** regarding the company's ability to continue as a going concern, pending the full successful execution of the turnaround plan.
* **Customer Concentration:** Historically, **95% of total sales** were attributed to a **single customer**, a risk the company is mitigating through global expansion in Nigeria and the UAE.
* **Labor Relations:** Following a dispute with the **Shramik Utkarsh Sabha** union, a **Memorandum of Settlement** was reached on **February 22, 2024**. The company is now managing the reinstatement of workers.
* **Market Risks:**
* **Currency:** Exposure to **USD** and **Euro** is managed via **Forward Contracts** (up to **90 days**).
* **Competition:** Intense pricing pressure from **Chinese and Indian manufacturers** is countered by a focus on **Japanese technology** and premium quality.
* **Regulatory:** Expansion is strictly contingent upon environmental clearances and effluent discharge norms from the **MPCB**.
---
### **Leadership Team**
The Board was reconstituted following the Heranba acquisition to align with the group's long-term vision:
* **Mr. Sadashiv K. Shetty:** Non-Executive Chairman (Term ends **March 2029**).
* **Mr. Raghuram K. Shetty:** Managing Director (Term ends **March 2029**).
* **Internal Auditor:** **M/s SPSJ & Associates LLP** (Appointed **April 2024**).